Indwelling Peritoneal Catheters for Managing Malignancy-Associated Ascites

• DOI: 10.1177/082585971503100406
• Publication Date: 2017-01-24T12:26:04Z
• Authors: Benson Chun To Wong; Lorraine Cake; Lynn Kachuik; Kayvan Amjadi
• Keywords: Ascitic fluid

We investigated use of the tunnelled catheter in a large palliative population with malignancy-associated ascites employing retrospective analysis prospectively maintained patient database peritoneal insertions for refractory or new rapidly accumulating ascites. found that 100 percent procedural success rate was achieved 395 catheters inserted 386 patients. Catheters remained situ 66 days, on average. In total 22 cases (5.57 percent), complications developed. Nonfatal infections occurred most commonly--in 15 (3.80 percent). Ascites stopped reaccumulating 16 (4.05 leading to removal. The mean Baseline Dyspnea Index 3.79 (95 confidence interval [CI], 3.64-3.94); Transitional postinsertion 5.14 CL, 4.94-5.34). all, 13 patients completed serial European Organisation Research and Treatment Cancer Quality Life Questionnaires. Postinsertion, overall quality life improved significantly (p < 0.05), as did all functional domains fatigue, pain, dyspnea, appetite symptoms. is feasible safe causes minimal complications. Its results significant improvement dyspnea small number